Pfizer
Flagship Pioneering, Quotient Therapeutics Team up for Pfizer Drug Discovery Partnership
Under the agreement, the companies aim to discover new drug targets in cardiovascular and renal diseases using Quotient's cell phenotyping and genomic sequencing platform.
BioMérieux, Pfizer, Malawi Ministry of Health Collaborate on Antimicrobial Resistance Effort
The effort will supply four central hospitals with diagnostics and training to support antimicrobial stewardship initiatives.
Thermo Fisher Scientific, Pfizer Canada Grant C$300K to Study NGS in Colorectal Cancer Care
The recipients of both grants will study the effects of bringing next-generation sequencing-based testing into a community cancer center.
FDA Approves Foundation Medicine CDx Tests for Pfizer's Braftovi-Mektovi Combo in Lung Cancer
The FoundationOne CDx and FoundationOne Liquid CDx tests were approved to determine whether patients with metastatic non-small cell lung cancer may be eligible for treatment.
Ginkgo Bioworks, Pfizer Ink RNA Drug Discovery Deal Worth up to $331M
The deal is the latest multimillion-dollar collaboration to come out of Ginkgo Bioworks' concerted effort to court the pharmaceutical industry in 2023.